Mosunetuzumab-axgb may be better tolerated by older adults with relapsed or refractory follicular lymphoma and patients with poor performance status.
Mallory Norman, PharmD, BCOP
Advertisement
Articles by Mallory Norman, PharmD, BCOP
Importantly, when considering the useof small molecule inhibitors, potential drug interactions must be evaluated.
Advertisement
Latest Updated Articles
Small Molecule Inhibitors for the Treatment of Chronic Lymphocytic LeukemiaPublished: April 16th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Addressing Drug Resistance in Lung Cancer
2
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
3
From Mutation to Medicine: Targeted Therapies in Lung Cancer
4
Tar-200 Plus Anti–PD-1 Therapy Shows Promising Neoadjuvant Activity in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
5
